LOVE — Cannara Biotech Share News
0.000.00%
Last trade - 00:00- CA$150.86m
- CA$163.19m
- CA$107.32m
Brief: Cannara Announces Strategic C$6.3 Million Non-Brokered Private Placement Priced At C$2.10 Per Common Share
Brief: Cannara Biotech Delivers Q4
Cannabis firm Cannara Biotech's Q4 revenue rises on market expansion
Brief: Cannara Biotech Q4 EPS CAD 0.04
Brief: Cannara Biotech Q3 EPS CAD 0.04
Brief: Cannara Biotech Q2 EPS CAD 0.04
Brief: Cannara Biotech Posts Quarterly Profit of 6 Canadian Cents
Brief: Cannara Biotech Inc Raised An Additional $10 Million Of Credit Facilities
Brief: Cannara Biotech Posts Q2 Net Revenue Of $13 Mln
Brief: Cannara Biotech Inc Reports Q1 2023 Financial Results
Brief: Cannara Announces Proposed Share Consolidation
Brief: Cannara Announces Normal Course Issuer Bid For Common Shares Of Corporation
Brief: Cannara Biotech Reports Q4 And 2022 Fiscal Year Financial Results
Brief: Cannara Signs An Exclusive Brand Partnership With Exotic Genetix In Canada
Brief: Cannara Signs An Exclusive Brand Partnership With Exotic Genetix In Canada
Brief: Cannara Biotech Inc. Reports Fiscal Third Quarter 2022 Financial Results
Brief: Cannara Biotech Inc. Closes $50 Mln Credit Facility Led By BMO Commercial Banking
Brief: Cannara Biotech Reports Fiscal Q2 2022 Financial Results
Brief: Cannara Biotech Inc. Reports Fiscal First Quarter 2022 Financial Results